MedTrace Logo

Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation

NCT01073202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2010-12-30

No results posted yet for this study

Summary

This study is designed to investigate the possible beneficial effects of UDCA on liver graft recovery early after adult liver transplantation.

Conditions

  • Liver Transplantation
  • Ischemia-reperfusion Injury
  • Cholestasis

Interventions

DRUG

ursodeoxycholic acid

13-15mg/kg/day, 250mg/capsule, given twice per day, within the first 4 weeks after liver transplantation

DRUG

identical-appearing placebo

13-15mg/kg/day, 250mg/capsule, given twice per day, within the first 4 weeks after liver transplantation

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Zhi-Hai Peng, MD · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2008-04-30
Completion
2009-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073202 on ClinicalTrials.gov